Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Chemical or Radiation/Nuclear (CRN) Threats
Forecasted
This grant supports research to develop and test new medical treatments and technologies for diagnosing, mitigating, and treating injuries from chemical or radiation/nuclear threats in civilian public health emergencies.
Funder: National Institutes of Health
Due Dates (Anticipated): October 2026 (Full application deadline, projected)
Funding Amounts: Not specified; cooperative agreement awards; see program for details.
Summary: Supports research and development of new concepts, technologies, and products to diagnose, mitigate, and treat effects of radiological, nuclear, or chemical exposures in civilian public health emergencies.
Key Information: This is a forecasted opportunity; all dates and details are subject to change.
Description
This funding opportunity, administered by the National Institute of Allergy and Infectious Diseases (NIAID) on behalf of the NIH, supports research on the development of candidate medical countermeasures (MCMs) and technologies to address civilian radiological, nuclear, or chemical threats. The program seeks to advance new ideas and products that can diagnose, mitigate, and treat both acute and delayed effects of such exposures in the context of public health emergencies.
Research focus areas include:
- Radiation/Nuclear Countermeasures Program (RNCP): Development of models, biomarkers, assessment devices, and products to improve survival and reduce morbidity from radiation exposure.
- Chemical Countermeasures Research Program (CCRP): Preclinical work on products to mitigate and treat injuries from government-designated Chemicals of Concern, especially those effective in post-exposure, mass casualty settings.
The program uses the U01 cooperative agreement mechanism and does not allow clinical trials.
